Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
10:30-11:30 AM Helsinki time
That's some solid due diligence right there
Great....
Same here, so 26 for me. Hell, I think i can let it stretch to 30 if need be lol.
All the bottomfeeder traders selling their shares again. People have no idea what's coming.
Traders seem to think this is a 'one and done' kind of stock much like every POS they try to scalp a couple bucks out. They have no idea what's in store.
Not seeing any new faces yet. Look out for overly optimistic posts about obvious company information with numerous exclamation marks and colorful text, written by members with 5,000+ posts and accounts older than 3-4 years.
This definitely was a sketchy run-up, but anything can happen. Looking at the 1-year chart from 06/2013 to now sure looks like accumulation to me.
Sit tight..
Amarantus Announces Two New Independent Peer-Reviewed Publications for MANF
http://ir.stockpr.com/amarantus/company-news/detail/834
Everything going on with this stock/board today..pathetic.
This TDA issue is indeed getting frustrating now. Hope it's resolved soon. After several phone calls, I've just been patiently waiting as prices dipped in the recent weeks.
REAL reputable, lol
Amarantus Posts Review of MANF Literature to Web Site
SUNNYVALE, Calif.-- Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, has posted to its Web site a White Paper titled “A Review of MANF Literature: Implications for the Development Program of Amarantus Bioscience Holdings.” The White Paper can be found at http://ir.stockpr.com/amarantus/scientific-publications.
“This extensive report on our lead therapeutic MANF is valuable to a number of audiences, including life science research professionals, potential development partners, and investors as they conduct due diligence to better understand the breadth of the technology,“ said Amarantus Chief Executive Officer Gerald Commissiong. “It is the most comprehensive discussion of the properties and potential of MANF, and we believe it will significantly enhance understanding of our MANF therapeutic program.”
Prepared by the consulting firm NeuroAssets, the 41-page report covers MANF’s protein structure and cellular activities; studies related to Parkinson’s disease, stroke, myocardial infarction and traumatic brain injury; and the potential for further development of MANF.
http://content.stockpr.com/amarantus/files/pdf/MANF+WhitePaper+2013-04-30+FINAL.pdf
Still unable to buy. Lots of longs on the sidelines still. PPS is being brought down on miniscule volume and all the promoters that are all of a sudden experts of AMBS aren't helping. So much NOISE, it's not worth sticking around. Holding my ~500,000 shares @ 0.04 avg and keeping an eye on only my AMBS-subscribed email alerts from here on out. Later.
Looks to be back to normal on ameritrade, finally..
Because share price will be substantially higher by then.
Yeah, lots of people still on the sidelines.
Tons of promotion going on for tomorrow. Expecting a ton of volume.
For those with TDA: Are you showing a 100% loss in AMBS with your original position under another CUSIP? That's what I've got ATM. Still unable to buy as well..
Still waiting on TDA...
New article bodes well for $RCON
http://www.coalguru.com/china/liquefied_natural_gas_industry_to_develop_fast_in_china/8978
Any updates on ameritrade and the chill/cusip issue? Still sitting on the sidelines with no holdings in my portfolio and unable to buy...
His posts really make this feel like a pump and dump, which is unfortunate because I truly believe in the company. It's like he's cycling through a lot of 20 different newsletter-esque posts every 2 minutes.
**CRICKETS** So much for the .068's being destroyed.
that's what happens when you guys sit and watch tick after tick. Either buy and hold for the long-term or get out.
Anyone having troubles seeing AMBS under their balances and positions? It shows under mine that it's a 100% loss and the new name is "02300T109"...has to be a joke.
I called in but all I got was "our service department is working on the issue and will have it fixed as soon as possible". This was just another issue for me and TDA. I'll be using a new broker within the next month.
Yup, i've done the same. Make it 5 mill
Such BS with this DTC chill. That was the last straw for me and TDA
Don't hold your breath.
DTC Chill? Are you serious?
Overall a great CC, imo. What really stood out at me wes the lack of "um" and "uh" between Gerald's answers. He was very clear and to the point, and I believe that says alot about his integrity, conviction, and overall confidence in the success of this company. Anyone disappointed with the CC needs to stop letting all the extra noise and overly exaggerated speculation on boards get to them.
Lots of speculation about PPS/CC going on.
My expectations are simple and from what I see, it seems difficult for anything to be taken as negative from the upcoming CC on the 16th. It happens to take place in the midst of Parkinson's Awareness Month, with another presentation by a reputable MD called "PD ExpertBriefing: Medical Therapies: What's in the PD Pipeline?" going on elsewhere around the same time. Coincidence? I don't know. But anticipating higher PPS/volume next week is reasonable and probable with the fundamentals of the company being where they currently are. It's that simple. No need for extra noise.
huge blocks comin through
750,000 on bid for split second
what a joke..